Adlai Nortye Group Ltd. Stock: price and insider trades · United States
Adlai Nortye Group Ltd.: what insiders have been doing
Adlai Nortye Group Ltd. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). Over the twelve months to 23 October 2026, 9 filings were filed, from 4 insiders.
No insider bought on the market over the period, while 3 insiders filed 7 sales totalling €358k. At €72k, the sale published on 24 September 2026 by Ji Ping is the largest of the period (0.011% of market cap).
The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For context, the typical company on the same exchange (median of 3,167 companies) published 24 filings over the same period, against 9 filings here. The full history, which starts in 2026, counts no purchases against 7 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Adlai Nortye Group Ltd. Strong Buy (bullish), based on 6 analysts. Average price target: US$29.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 214 shares@ US$15.770.0003% mcap1.4% of flowAmerican Depository sharesSEC:0002129331-26-000006:0
- 5,000 shares@ US$16.030.0081% mcap32.6% of flowAmerican Depository sharesSEC:0002129331-26-000006:1
- 5,000 shares@ US$15.950.0080% mcap32.5% of flowAmerican Depository sharesSEC:0002129331-26-000006:2
- 5,000 shares@ US$16.630.011% mcap33.5% of flowAmerican Depository sharesSEC:0002129331-26-000005:0
- 80,000 sharesAmerican Depository SharesSEC144:0002129331-26-000004
- 6,000 shares@ US$13.980.0082% mcap50.9% of flowAmerican Depositary SharesSEC:0002136887-26-000002:0
- 5,667 shares@ US$14.250.0079% mcap49.1% of flowAmerican Depositary SharesSEC:0002136887-26-000002:1
- 136,667 sharesAmerican Depository sharesSEC:0002129331-26-000003:0
- 10 shares@ US$13.18100.0% of flowAmerican Depositary SharesSEC:0002136295-26-000002:0
9 of 9 declarations
About Adlai Nortye Group Ltd.
Adlai Nortye Group Ltd. is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on NASDAQ under the ticker ANTE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
